Literature DB >> 25251876

Lung function abnormalities in HIV-infected adults and children.

Gregory L Calligaro1, Diane M Gray.   

Abstract

Despite the advent of antiretroviral therapy (ART), the human immunodeficiency virus (HIV) epidemic remains a global health crisis with a high burden of respiratory disease among infected persons. While the early complications of the epidemic were dominated by opportunistic infections, improved survival has led to the emergence of non-infectious conditions that are associated with chronic respiratory symptoms and pulmonary disability. Obstructive ventilatory defects and reduced diffusing capacity are common findings in adults, and the association between HIV and chronic obstructive pulmonary disease is increasingly recognized. There is synergism between viral factors, opportunistic infections, conventional influences like tobacco smoke and biomass fuel exposure, and potentially, the immunological effects of ART on the development of HIV-associated chronic obstructive lung disease. Pulmonary function data for HIV-infected infants and children are scarce, but shows that bronchiectasis and obliterative bronchiolitis with severe airflow limitation are major problems, particularly in the developing world. However, studies from these regions are sorely lacking. There is thus a major unmet need to understand the influences of chronic HIV infection on the lung in both adults and children, and to devise strategies to manage and prevent these diseases in HIV-infected individuals. It is important for clinicians working with HIV-infected individuals to have an appreciation of their effects on measurements of lung function. This review therefore summarizes the lung function abnormalities described in HIV-positive adults and children, with an emphasis on obstructive lung disease, and examines potential pathogenic links between HIV and the development of chronic pulmonary disability.
© 2014 Asian Pacific Society of Respirology.

Entities:  

Keywords:  chronic obstructive pulmonary disease; diffusing capacity; human immunodeficiency virus infection; obstructive lung disease; pulmonary complications of human immunodeficiency virus.

Mesh:

Year:  2014        PMID: 25251876     DOI: 10.1111/resp.12385

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  13 in total

1.  Lung Function in South African Adolescents Infected Perinatally with HIV and Treated Long-Term with Antiretroviral Therapy.

Authors:  Leah Nyawira Githinji; Diane M Gray; Sipho Hlengwa; Landon Myer; Heather J Zar
Journal:  Ann Am Thorac Soc       Date:  2017-05

2.  Follicular bronchiolitis in an HIV-infected individual on combination antiretroviral therapy with low CD4+ cell count but sustained viral suppression.

Authors:  Line D Rasmussen; Court Pedersen; Helle D Madsen; Christian B Laursen
Journal:  BMJ Case Rep       Date:  2017-11-29

3.  Incident obstructive lung disease and mortality among people with HIV and a history of injecting drugs.

Authors:  Mariah M Kalmin; Daniel Westreich; Bradley M Drummond; Jing Sun; Shruti H Mehta; Gregory D Kirk
Journal:  AIDS       Date:  2021-07-15       Impact factor: 4.632

Review 4.  The epidemiology of noncommunicable respiratory disease in sub-Saharan Africa, the Middle East, and North Africa.

Authors:  Rana Ahmed; Ryan Robinson; Kevin Mortimer
Journal:  Malawi Med J       Date:  2017-06       Impact factor: 0.875

5.  History of tuberculosis is associated with lower exhaled nitric oxide levels in HIV-infected children.

Authors:  Evgeniya Sovershaeva; Katharina Kranzer; Grace Mchugh; Tsitsi Bandason; Edith D Majonga; Omar S Usmani; Sarah Rowland-Jones; Tore Gutteberg; Trond Flægstad; Rashida A Ferrand; Jon Ø Odland
Journal:  AIDS       Date:  2019-09-01       Impact factor: 4.177

6.  Macrophage HIV-1 Gene Expression and Delay Resolution of Inflammation in HIV-Tg Mice.

Authors:  Marina Jerebtsova; Asrar Ahmad; Namita Kumari; Ornela Rutagarama; Sergei Nekhai
Journal:  Viruses       Date:  2020-03-01       Impact factor: 5.048

7.  HIV-1 Transcription Inhibitor 1E7-03 Restores LPS-Induced Alteration of Lung Leukocytes' Infiltration Dynamics and Resolves Inflammation in HIV Transgenic Mice.

Authors:  Marina Jerebtsova; Asrar Ahmad; Xiaomei Niu; Ornela Rutagarama; Sergei Nekhai
Journal:  Viruses       Date:  2020-02-12       Impact factor: 5.048

Review 8.  The Role of the Immune Response in the Pathogenesis of Bronchiectasis.

Authors:  Paul T King
Journal:  Biomed Res Int       Date:  2018-03-18       Impact factor: 3.411

9.  Impact of comorbidity on the risk and cost of hospitalization in HIV-infected patients: real-world data from Abruzzo Region.

Authors:  Simona Cammarota; Anna Citarella; Lamberto Manzoli; Maria Elena Flacco; Giustino Parruti
Journal:  Clinicoecon Outcomes Res       Date:  2018-07-23

Review 10.  Antimicrobial Resistance in Common Respiratory Pathogens of Chronic Bronchiectasis Patients: A Literature Review.

Authors:  Riccardo Inchingolo; Chiara Pierandrei; Giuliano Montemurro; Andrea Smargiassi; Franziska Michaela Lohmeyer; Angela Rizzi
Journal:  Antibiotics (Basel)       Date:  2021-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.